Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 29.70
+1.70 (6.07%)
At close: Feb 10, 2026
Orion Pharma Revenue
Orion Pharma had revenue of 748.15M BDT in the quarter ending December 31, 2025, a decrease of -13.05%. This brings the company's revenue in the last twelve months to 3.12B, down -57.77% year-over-year. In the fiscal year ending June 30, 2025, Orion Pharma had annual revenue of 4.08B, down -61.57%.
Revenue (ttm)
3.12B
Revenue Growth
-57.77%
P/S Ratio
2.23
Revenue / Employee
1.06M
Employees
2,954
Market Cap
6.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 4.08B | -6.54B | -61.57% |
| Jun 30, 2024 | 10.62B | -3.31B | -23.74% |
| Jun 30, 2023 | 13.93B | 4.26B | 44.14% |
| Jun 30, 2022 | 9.66B | -1.17B | -10.81% |
| Jun 30, 2021 | 10.83B | 3.18B | 41.64% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The ACME Laboratories | 38.86B |
| The IBN SINA Pharmaceutical Industry | 13.42B |
| Beacon Pharmaceuticals | 11.58B |
| Navana Pharmaceuticals | 9.52B |
| Techno Drugs | 3.15B |
| Asiatic Laboratories | 2.24B |
| Pharma Aids | 453.49M |
| Silco Pharmaceuticals | 428.63M |